EFA strengthened its Climate Change programme in 2024, ensuring that allergy, asthma, and COPD patients are at the centre of discussions on climate-related health risks. Building on our 2023-2025 strategic plan, we deepened our focus on the health impacts of climate-driven factors such as air pollution, extreme heat, pollen, sandstorms, and wildfire emissions.
Throughout 2024, we worked closely with our patient community to develop patient-centred information and recommendations on environmental determinants of health.
EFA also expanded its role as a key stakeholder in EU policy discussions, advocating for stronger measures to protect respiratory and allergy patients from climate-related health threats. Through these efforts, we reinforced our commitment to ensuring that climate policies reflect the needs and lived experiences of those most vulnerable to its effects.
In 2025, we will further strengthen our advocacy efforts by engaging policymakers and patient communities as well as broaden our search for EU-funding opportunities to ensure that climate adaptation and mitigation policies fully integrate health considerations, particularly for allergy and respiratory patients.